
Our
Brand

Believe in Life is our company motto. It drives our core mission: to provide high-quality, affordable pharmaceuticals worldwide. It stands for hope on the path to health recovery. Behind every prescription is a patient, a family, and a journey toward a healthier tomorrow. As a global pharmaceutical company, this belief guides every decision we make, ensuring that our dedication to quality, innovation, and accessibility touches the lives of the people who need it most.

Galen
Our name is inspired by Galen of Pergamon (129–216 AD), the Roman Empire’s premier physician and philosopher. His pioneering work in anatomy, physiology, and pharmacology laid the foundation for modern medicine and scientific logic—a legacy of rigorous science and care that continues to guide our work today.

Rising logo
Just as dawn signals the transition from darkness to light, sunrise represents the vital moment of recovery. The lower part of our logo represents the sun at sunrise, symbolizing the spirit of overcoming.
Our
Values
Our values reflect the essence of our culture, which we want to preserve regardless of time and business scale. Our values contribute to continuing gaining ground in our business purpose, but they also guide our day-to-day behaviours, decisions and relationships.
Encompassing value

Integrity
Booster values

Creativity

Energy

Adaptability
Core values

Commitment

Connection

Challenge
Our
History
2009
Awarding of the first patent for Galenicum
2009
Awarding of the first patent for Galenicum
The Grand Journey
The Grand Journey. The first episode of a trilogy of short films about the renovation of an old industrial warehouse to become the new Galenicum headquarters and R&D center. This one is about how the idea started.
The Grand Renovation. The second episode where the transformation of the new building is in full swing showing all the buzz and fuzz of a working site.
This is life
Ethics and governance are integral to what we do, not just a policy. We drive transparency by embedding rigorous standards and a culture of integrity directly into our business and our entire ESG strategy, encompassing all three pillars.

Believe
in sharing life
Investing in human health, talent, and social growth.
We foster an inclusive workplace culture while building strong ties with local communities. We prioritize employee well-being by promoting healthy habits and active lifestyles. Committed to advancing the scientific community, we partner with universities to empower young researchers while driving internal growth through Galenicum Laude.

Believe
in greener life
Reducing our environmental footprint through efficient pharmaceutical manufacturing.
We protect the environment by transforming our manufacturing practices to reduce our footprint and work toward Net-Zero. Through resource efficiency, we continuously lower energy, water, and gas consumption per unit. Guided by a circular economy mindset, we maintain a Zero Waste to Landfill commitment by reintroducing materials back into the production chain. Additionally, advanced water discharge treatment ensures strict effluent quality to protect local ecosystems.

Believe
in the product’s life
Committed to affordability: Expanding global access to high-quality healthcare.
Affordability drives our ESG strategy. By developing high-quality bioequivalent medicines, we bring essential treatments to patients worldwide. As we evolve into Specialty Pharma, we maintain this commitment to affordability and focused innovation in key therapeutic areas like diabetes and obesity (GLP-1). We ensure complete supply chain accountability, applying strict supplier standards and responsible sourcing from development to patient delivery.
Gas Intensity
Reduction vs 2024 / kWh per 1,000 units
-3%
Solar Energy
Clean power during peak sunny hours
100%
Manufacturing Capacity
Packs per year
+100M
Electricity Intensity
Reduction vs 2024 / kWh per 1,000 units
-11%
Water Consumption
Reduction vs 2024 / Total m³
-13%
Our
ESG Numbers
2025
Pharmacovigilance
Report on suspected adverse drug reactions T +34 932 011 750 - (extension 4) pharmacovigilance@galenicum.com
Compliance
Pharmacovigilance
Report on suspected adverse drug reactions T +34 932 011 750 - (extension 4) pharmacovigilance@galenicum.com
Compliance
Reports
Annual Report 2025
EINF 2024




